Release Date: 21/09/10 14:18 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 56.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%